Neuroproteomics

Methods and Protocols
2009
ISBN: 978-1-61779-754-5
Verlag: Humana Press

Buch, Englisch, Band 566, 321 Seiten, Previously published in hardcover, Format (B × H): 210 mm x 279 mm, Gewicht: 821 g

Reihe: Methods in Molecular Biology

Neuroproteomics: Methods and Protocols presents experimental details for applying proteomics to the study of the central nervous system (CNS) and its dysfunction through trauma and disease. The target audience includes clinical or basic scientists who look to apply proteomics to the neurosciences. Often researchers hear of proteomics without an adequate explanation of the methodology and inherent limitations. This volume conveys where proteomic methodology is in its application to CNS research and what results can be expected. We also address clinical translation of neuroproteomics, specifically in the area of biomarker research. The inception of neuroproteomics capitalized on rapid progress in large-molecule mass spectrometry over the last decade. Two seminal advances have spurred research – development of reliable polypeptide ionization processes and bioinformatics to rapidly process tandem mass spectra for peptide identification and quantification. What has followed is the exponential application of mass spectrometry to proteome characteri- tion across biological and biomedical disciplines. Arguably, the most elaborate proteomic implementation is in studying the CNS, the most enigmatic and complex animal system. Neuroscience is characterized by grandiose questions – what is consciousness, how does thought or memory work. Neuroproteomics researchers, however, have pri- rily involved themselves dysfunction, based on a pressing need (and invariably funding), in answering questions on CNS dysfunction, based on a pressing need (and invariably funding), and because such questions hold more accessible answers. Dysfunction is readily contrasted against normal function and presumably produces a lasting differential protein signature.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Wang, Kevin K. W.

Ottens, Andrew K.

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie

Inhaltsverzeichnis

Disease Models in Neuroproteomics.- The Methodology of Neuroproteomics.- Modeling Cerebral Ischemia in Neuroproteomics.- Clinical and Model Research of Neurotrauma.- Neuroproteomic Methods in Spinal Cord Injury.- Modeling Substance Abuse for Applications in Proteomics.- Protein Aggregate Characterization in Models of Neurodegenerative Disease.- Sub-Proteome Separations and Neuroproteomic Analysis.- Sub-Proteome Processing: Isolation of Neuromelanin Granules from the Human Bra.- Proteomic Analysis of Protein Phosphorylation and Ubiquitination in Alzheimer’s Disease.- Proteomics Identification of Carbonylated and HNE-Bound Brain Proteins in Alzheimer’s Disease.- Mass Spectrometric Identification of In Vivo Nitrotyrosine Sites in the Human Pituitary Tumor Proteome.- Improved Enrichment and Proteomic Analysis of Brain Proteins with Signaling Function by Heparin Chromatography.- Calmodulin-Binding Proteome in the Bra.- Neuroproteomic Methodology and Bioinformatics.- Separation of the Neuroproteome by Ion Exchange Chromatography.- iTRAQ-Based Shotgun Neuroproteomics.- Methods in Drug Abuse Neuroproteomics: Methamphetamine Psychoproteome.- Shotgun Protein Identification and Quantification by Mass Spectrometry in Neuroproteomics.- Biofluid Analysis and Clinical Translation.- Identification of Glycoproteins in Human Cerebrospinal Fluid.- Mass Spectrometric Analysis of Body Fluids for Biomarker Discovery.- Traumatic Brain Injury Biomarkers: From Pipeline to Diagnostic Assay Development.- Translation of Neurological Biomarkers to Clinically Relevant Platforms.